Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and in vivo anti-inflammatory effect by using HET-CAM assay

References

• Kumar C. Nanotechnology tools in pharmaceutical R&D. Mater Today. 2010;12(1):24–30.
   Google Scholar
• Öztürk AA, Martin-Banderas L, Cayero-Otero MD, et al. Dexketoprofen trometamol-loaded Poly-Lactic-co-Glycolic Acid (PLGA) nanoparticles: preparation, in vitro characterization and cytotoxicity. Trop J Pharm Res. 2019;18(1):1–11.
   Web of Science ®Google Scholar
• Öztürk AA, Martin-Banderas L, Cayero Otero MD, et al. New approach to hypertension treatment: carvedilol-loaded plga nanoparticles, preparation, in vitro characterization and gastrointestinal stability. Latin Am J Pharm. 2018;37:1730.
   Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (plga) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3):1377–1397.
   PubMed Web of Science ®Google Scholar
• Öztürk AA, Çinar Nİ, Yenilmez E. Development of nano-sized ketoprofen lysine incorporated Eudragit® S100 nanomedicine by double emulsion solvent evaporation and in vitro characterization. J Pharm Pharmacogn Res. 2019;7(1):47–58.
   Web of Science ®Google Scholar
• Öztürk AA, Güven UM, Yenilmez E, et al. Effects of different derivatives of eudragit polymer on entrapment efficiency, in vitro dissolution, release kinetics and cell viability results on extended release flurbiprofen loaded nanomedicines. Lat Am J Pharm. 2018;37(10):1981–1992.
   Web of Science ®Google Scholar
• Öztürk AA, Güven UM, Yenilmez E. Flurbiprofen loaded gel based topical delivery system: formulation and in vitro characterization with new developed UPLC method. Acta Pharm Sci. 2018;56(4):81–105.
   Google Scholar
• Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: design, evaluation and state-of-the-art. J Control Release. 2016;240:504–526.
   PubMed Web of Science ®Google Scholar
• Bürgermeister J, Paper DH, Vogl H, et al. LaPSvS1, a (1→3) β-galactan sulfate and its effect on angiogenesis in vivo and in vitro. Carbonhydr Res. 2002;337(16):1459–1466.
   PubMed Web of Science ®Google Scholar
• Krenn L, Paper DH. Inhibition of angiogenesis and inflammation by an extract of red clover (Trifolium pratense L.). Phytomedicine. 2009;16(12):1083–1088.
   PubMed Web of Science ®Google Scholar
• Janagam DR, Wu L, Lowe TL. Nanoparticles for drug delivery to the anterior segment of the eye. Adv Drug Deliv Rev. 2017;122:31–64.
   PubMed Web of Science ®Google Scholar
• Öztürk AA, Kıyan HT. Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: formulation, characterization and anti-inflammatory activity by using in vivo. Microvasc Res. 2020;128:103961.
   PubMed Web of Science ®Google Scholar
• Öztürk AA, Namlı İ, Güleç K, et al. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: formulation, characterization and in vivo HET-CAM analysis. Microvasc Res. 2020;130:103991. DOI:10.1016/j.mvr.2020.103991
   Google Scholar
• Wilson TD, Steck WF. A modified HET-CAM assay approach to the assessment of anti-irritant properties of plant extracts. Food Chem Toxicol. 2000;38(10):867–872.
   PubMed Web of Science ®Google Scholar
• Kumar R, Sinha VR. Solid lipid nanoparticle: an efficient carrier for improved ocular permeation of voriconazole. Drug Dev Ind Pharm. 2016;42(12):1956–1967.
   PubMed Web of Science ®Google Scholar
• Ribatti D, Nico B, Vacca A, et al. Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat Rec. 2001;264(4):317–324.
   PubMedGoogle Scholar
• Zhang Y, Huo M, Zhou J, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12(3):263–271.
   PubMed Web of Science ®Google Scholar
• Stockert JC, Blázquez-Castro A, Canete M, et al. MTT assay for cell viability: intracellular localization of the formazan product is in lipid droplets. Acta Histochem. 2012;114(8):785–796.
   PubMed Web of Science ®Google Scholar
• Uchida M, Li XW, Mertens P, et al. Transfection by particle bombardment: delivery of plasmid DNA into mammalian cells using gene gun. Biochim Biophys Acta. 2009;1790(8):754–764.
   PubMed Web of Science ®Google Scholar
• Seow L, Beh H, Sadikun A, et al. Evaluation of anti-inflammatory effect of traditional medicinal plants Gynura segetum. TANG. 2014;4:e4.
   Google Scholar
• Kıyan HT. Bazı Hypericum türlerinin uçucu yağ bileşimleri ve antianjiyojenik aktiviteleri, Yüksek Lisans Tezi, Sağlık Bilimleri Enstitüsü, Farmakognozi Anabilim Dalı, Eskişehir, Turkey; 2010.
   Google Scholar
• Mittal G, Sahana DK, Bhardwaj V, et al. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release. 2007;119(1):77–85.
   PubMed Web of Science ®Google Scholar
• Martín-Banderas L, Alvarez-Fuentes J, Durán-Lobato M, et al. Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies. Int J Nanomed. 2012;7:5793–5806.
   PubMed Web of Science ®Google Scholar
• Palacio J, Orozco VH, López BL. Effect of the molecular weight on the physicochemical properties of poly(lactic acid) nanoparticles and on the amount of ovalbumin adsorption. J Braz Chem Soc. 2011;22(12):2304–2311.
   Web of Science ®Google Scholar
• Şenel B, Öztürk AA. New approaches to tumor therapy with siRNA-decorated and chitosan-modified PLGA nanoparticles. Drug Dev Ind Pharm. 2019;45(11):1835–1848.
   PubMed Web of Science ®Google Scholar
• Berrocoso E, Rey-Brea R, Fernandez-Arevalo M, et al. Single oral dose of cannabinoid derivate loaded PLGA nanocarriers relieves neuropathic pain for eleven days. Nanomedicine. 2017;13(8):2623–2632.
   PubMed Web of Science ®Google Scholar
• Emami J, Mohiti H, Hamishehkar H, et al. Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design. Res Pharm Sci. 2015;10(1):17–33.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161–177.
   PubMed Web of Science ®Google Scholar
• Panyam J, Williams D, Dash A, et al. Solid-state solubility infuences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J Pharm Sci. 2004;93(7):1804–1814.
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang C. Tuning the size of poly(lactic-co-glycolic acid) (PLGA) nanoparticles fabricated by nanoprecipitation. Biotechnol J. 2018;13(1):1–19.
   Web of Science ®Google Scholar
• Öztürk AA, Yenilmez E, Şenel B, et al. Dexketoprofen trometamol-loaded kollidon® SR and eudragit® RS 100 polymeric nanoparticles: formulation and in vitro-in vivo evaluation. J Res Pharm. 2020;24(1):1–2165.
   Google Scholar
• de Azevedo CR, Stosch M, Costa MS, et al. Modeling of the burst release from PLGA micro- and nanoparticles as function of physicochemical parameters and formulation characteristics. Int J Pharm. 2017;532(1):229–240.
   PubMedGoogle Scholar
• Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Released. 2001;73(2–3):121–136.
   PubMed Web of Science ®Google Scholar
• Yang H, Li J, Patel SK, et al. Design of poly(lactic-co-glycolic Acid) (PLGA) nanoparticles for vaginal co-delivery of griffithsin and dapivirine and their synergistic effect for HIV prophylaxis. Pharmaceutics. 2019;11(4):184–121.
   Web of Science ®Google Scholar
• Öztürk AA, Yenilmez E, Özarda G. Clarithromycin-loaded poly (lactic-co-glycolic acid) (PLGA) nanoparticles for oral administration: effect of polymer molecular weight and surface modification with chitosan on formulation, nanoparticle characterization and antibacterial effects. Polymers. 2019;11(10):1632.
   PubMed Web of Science ®Google Scholar
• Sohail MF, Shah PA, Tariq I, et al. Development and in vitro evaluation of flurbiprofen microcapsules prepared by modified solvent evaporation technique. Trop J Pharm Res. 2014;13(7):1031–1038.
   Web of Science ®Google Scholar
• Öztürk AA, Aygül A, Şenel B. Influence of glyceryl behenate, tripalmitin and stearic acid on the properties of clarithromycin incorporated solid lipid nanoparticles (SLNs): formulation, characterization, antibacterial activity and cytotoxicity. J Drug Sci Technol. 2019;54:101240.
   Web of Science ®Google Scholar
• Vega E, Gamisans F, Garcia ML, et al. PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions. J Pharm Sci. 2008;97(12):5306–5317.
   PubMed Web of Science ®Google Scholar
• Gamisans F, Lacoulonche F, Chauvet A, et al. Flurbiprofen-loaded nanospheres: analysis of the matrix structure by thermal methods. Int J Pharm. 1999;179(1):37–48.
   PubMedGoogle Scholar
• Öztürk AA, Yenilmez E, Yazan Y. Dexketoprofen trometamol-loaded Eudragit® RL 100 nanoparticle formulation, characterization and release kinetics. actapharm. 2019;57(1):69–84.
   Google Scholar
• Nath N, Liu X, Jacobs L, et al. Flurbiprofen benzyl nitrate (NBS-242) inhibits the growth of A-431 human epidermoid carcinoma cells and targets β-catenin. Drug Des Devel Ther. 2013;7:389–396.
   PubMed Web of Science ®Google Scholar
• Chan DC, Gera L, Zhang Z, et al. Abstract 1941: development of novel NSAID conjugated molecules for lung cancer therapy. Cancer Res. 2012;72(8):1941–1941.
   Google Scholar
• Amrite AC, Kompella UB. Celecoxib inhibits proliferation of retinal pigment epithelial and choroid-retinal endothelial cells by a cyclooxygenase-2-independent mechanism. J Pharmacol Exp Ther. 2008;324(2):749–758.
   PubMed Web of Science ®Google Scholar
• Cordewener FW, van Geffen MF, Joziasse CAP, et al. Cytotoxicity of poly(96L/4D-lactide): the influence of degradation and sterilization. Biomaterials. 2000;21(23):2433–2442.
   PubMed Web of Science ®Google Scholar
• Luo L, Li DQ, Pflugfelder SC. Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways. Cornea. 2007;26(4):452–460.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim M, Im YS, Choi W, et al. NFAT5 induction and its role in hyperosmolar stressed human limbal epithelial cells. Invest Ophthalmol Vis Sci. 2008;49(5):1827–1835.
   PubMed Web of Science ®Google Scholar
• Singh RP, Ramarao P. Accumulated polymer degradation products as effector molecules in cytotoxicity of polymeric nanoparticles. Toxicol Sci. 2013;136(1):131–143.
   PubMed Web of Science ®Google Scholar
• Morikawa Y, Tagami T, Hoshikawa A, et al. The use of an efficient microfluidic mixing system for generating stabilized polymeric nanoparticles for controlled drug release. Biol Pharm Bull. 2018;41(6):899–907.
   PubMed Web of Science ®Google Scholar
• Cegnar M, Premzl A, Zavasnik-Bergant V, et al. Poly(lactide-co-glycolide) nanoparticles as a carrier system for delivering cysteine protease inhibitor cystatin into tumor cells. Exp Cell Res. 2004;301(2):223–231.
   PubMed Web of Science ®Google Scholar
• Huang J, Zhang H, Yu Y, et al. Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer. Biomaterials. 2014;35(1):550–566.
   PubMed Web of Science ®Google Scholar
• Katsikari A, Patronidou C, Kiparissides C, et al. Uptake and cytotoxicity of poly(d,l-lactide-co-glycolide) nanoparticles in human colon adenocarcinoma cells. Mat Sci Eng B. 2009;165(3):160–164.
   Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, et al. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 2002;82(1):105–114.
   PubMed Web of Science ®Google Scholar
• Aydin E, Badilli U, Onay-Besikci A, et al. Thermosensitive in situ gel formulation containing plga nanoparticles of flurbiprofen for ocular delivery. Acta Pol Pharm. 2018;75(1):141–153.
   Web of Science ®Google Scholar
• Mahasen AR, Aboul-Enein YH. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats. Chirality. 2004;16(2):119–125.
   PubMed Web of Science ®Google Scholar
• Tariq M, Iqbal Z, Ali J, et al. Development and validation of a stability-indicating high-performance thin-layer chromatographic method for the simultaneous quantification of sparfloxacin and flurbiprofen in nanoparticulate formulation. JPC. 2014;27(2):124–131.
   Google Scholar
• Schrage A, Gamer AO, Ravenzwaay B, et al. Experience with the HET-CAM method in the routine testing of a broad variety of chemicals and formulations. ATLA. 2010;38(1):39–52.
   Google Scholar
• Steiling W, Bracher M, Courtellemont P, et al. The HET-CAM, a useful in vitro assay for assessing the eye irritation properties of cosmetic formulations and ingredients. Toxicol In Vitro. 1999;13(2):375–384.,
   PubMed Web of Science ®Google Scholar
• Ribatti D. The chick embryo chorioallantoic membrane (CAM). A multifaceted experimental model. Mech Dev. 2016;141:70–77.
   PubMed Web of Science ®Google Scholar
• Kue CS, Tan KY, Lam ML, et al. Chick embryo chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anti-cancer drugs. Exp Anim. 2015;64(2):129–138.
   PubMed Web of Science ®Google Scholar